📍 NEW YORK, USA
LIVE
Moderna and Merck announce mRNA cancer vaccine slashes recurrence and death by 42 percent
Biopharmaceutical giants Moderna and Merck have announced breakthrough clinical findings showing that their investigational mRNA cancer vaccine, when administered in conjunction with standard immunotherapy treatments, re...